TOLL 2024

17.04.2024 - 20.04.2024 Rotterdam


I am pleased to invite you to the 7th TOLL Conference that promises to be both enlightening and transformative for the future of immunology. TOLL 2024 Conference, as always, aims to present the latest research and developments in the role and mechanisms of innate immunity in health and disease.


TOLL 2024

Rotterdam, The Netherlands

April 17-20, 2024


Abstract Submission & Registration Open for TOLL 2024!


Elevate your research and expertise by participating in the TOLL 2024, dedicated to showcasing and challenging the most recent developments in cellular innate immunity. 


Here's why you should be a part of this transformative conference:

  • Premier Platform: TOLL 2024 offers a prestigious platform to present your research, engage with peers, and contribute to groundbreaking discussions shaping the future of immunology.
  • Cutting-Edge Content: Be at the forefront of innovation! Explore the latest advancements, methodologies, and discoveries in cellular innate immunity, and reshape conventional thinking with your unique perspectives.
  • Networking Opportunities: Connect with a global community of scientists, researchers, and industry leaders. Forge collaborations, share perspectives, and expand your professional network.
  • Professional Development: Enhance your knowledge, gain visibility in the field, and foster collaborations that could lead to future breakthroughs in immunological research.
  • Impactful Contributions: Your participation contributes to a collective effort to advance our understanding of cellular innate immunity, driving progress and innovation in the field.

Key Dates:

Don't miss the opportunity to be part of this exclusive experience that could redefine the future of immunology. Submit your abstract and register today!


Detailed information about abstract submission and registration can be found on the TOLL 2024 website.


Learn more about TOLL 2024 and all the opportunities here -




Go Back


Sanofi Innovation Award 2024:
Novel Approaches in Type 2 Inflammation
With this award, Sanofi supports residents and senior physicians who are clinically active in allergology/clinical immunology in Switzerland and whose translational scientific work deals with the topic of type 2 inflammation and related diseases.The award is endowed with CHF 10’000 and is intended for the execution of a scientific project.

Read More



With great pleasure we invite you to join us at the 2024 Continuing Education Meeting for Medical Laboratory Immunology in Switzerland organized by the Commission on Laboratory Diagnostics (CLD) of the Swiss Society for Allergology and Clinical Immunology (SSAI), which takes place on Friday November 22nd, 2024 in Aarau.


Read More

SSAI Annual Congress 2024

Bild Webseite Announcement v10